title: Neurobiologic Advances from the Brain Disease Model of Addiction.
authors.forename: Nora D
authors.initials: ND
authors.lastname: Volkow
authors.forename: George F
authors.initials: GF
authors.lastname: Koob
authors.forename: A Thomas
authors.initials: AT
authors.lastname: McLellan
mesh_terms: D001927:Brain Diseases / Q000503:physiopathology*; D006801:Humans; D008959:Models, Neurological; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000503:physiopathology* / Q000523:psychology
references.citation: Nat Neurosci. 1999 Oct;2(10):861-3
references.pmid: 10491603
references.citation: Am J Manag Care. 2014;20(1):76-82
references.pmid: 24512166
references.citation: J Neurosci. 2015 Aug 19;35(33):11572-82
references.pmid: 26290234
references.citation: Neuron. 2002 Oct 10;36(2):229-40
references.pmid: 12383779
references.citation: J Neurosci. 2006 Jun 14;26(24):6583-8
references.pmid: 16775146
references.citation: Lancet Psychiatry. 2015 Aug;2(8):677-679
references.pmid: 26249284
references.citation: Eur J Neurosci. 2012 Oct;36(7):2979-88
references.pmid: 22775285
references.citation: Psychopharmacology (Berl). 2015 Jan;232(2):331-41
references.pmid: 24973896
references.citation: Psychopharmacology (Berl). 2014 Apr;231(8):1437-53
references.pmid: 24464527
references.citation: Curr Opin Pharmacol. 2005 Feb;5(1):9-19
references.pmid: 15661620
references.citation: Nature. 2013 Apr 11;496(7444):224-8
references.pmid: 23515155
references.citation: Annu Rev Clin Psychol. 2014;10:243-73
references.pmid: 24471372
references.citation: Arch Gen Psychiatry. 1995 Mar;52(3):219-29
references.pmid: 7872850
references.citation: Nature. 2015 Jun 25;522(7557):S62
references.pmid: 26107100
references.citation: JAMA. 2001 Oct 10;286(14):1715-23
references.pmid: 11594896
references.citation: Mol Psychiatry. 2014 Sep;19(9):1037-43
references.pmid: 24912491
references.citation: Neuropharmacology. 2013 Apr;67:259-66
references.pmid: 23164614
references.citation: Nat Neurosci. 2005 Nov;8(11):1442-4
references.pmid: 16251985
references.citation: Nat Rev Neurosci. 2011 Oct 20;12(11):652-69
references.pmid: 22011681
references.citation: Neuron. 2002 Oct 10;36(2):241-63
references.pmid: 12383780
references.citation: Child Dev. 2011 Jan-Feb;82(1):405-32
references.pmid: 21291449
references.citation: Curr Behav Neurosci Rep. 2014 Mar 1;1(1):33-44
references.pmid: 25045619
references.citation: J Adolesc Health. 2012 Jun;50(6):559-64
references.pmid: 22626481
references.citation: Br J Clin Pharmacol. 2014 Feb;77(2):253-63
references.pmid: 23210630
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references.pmid: 19710631
references.citation: Hum Genet. 2012 Jun;131(6):773-7
references.pmid: 22562404
references.citation: Dev Psychopathol. 2013 Feb;25(1):223-39
references.pmid: 22824055
references.citation: Nature. 1997 Apr 24;386(6627):830-3
references.pmid: 9126741
references.citation: Ann N Y Acad Sci. 1992 Jun 28;654:171-91
references.pmid: 1632582
references.citation: PLoS One. 2012;7(5):e34917
references.pmid: 22606228
references.citation: Alcohol Clin Exp Res. 2005 Jun;29(6):989-98
references.pmid: 15976525
references.citation: Alcohol Clin Exp Res. 2015 Apr;39(4):579-84
references.pmid: 25833016
references.citation: Nat Rev Neurosci. 2015 Mar;16(3):173-84
references.pmid: 25697160
references.citation: Nat Rev Neurosci. 2007 Nov;8(11):844-58
references.pmid: 17948030
references.citation: Alcohol Clin Exp Res. 2011 Jan;35(1):140-55
references.pmid: 21039636
references.citation: J Stud Alcohol Drugs Suppl. 2014;75 Suppl 17:108-15
references.pmid: 24565317
references.citation: Neurosci Biobehav Rev. 2010 Nov;35(2):185-211
references.pmid: 20109488
references.citation: Drug Alcohol Depend. 2013 Nov 1;133(1):80-5
references.pmid: 23827259
references.citation: Neuropsychopharmacology. 2012 Mar;37(4):986-95
references.pmid: 22113088
references.citation: Prog Brain Res. 2008;169:199-207
references.pmid: 18394475
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):105-35
references.pmid: 19693004
references.citation: Cell. 2015 Aug 13;162(4):712-25
references.pmid: 26276628
references.citation: Curr Psychiatry Rep. 2013 Dec;15(12):420
references.pmid: 24173656
references.citation: Curr Opin Neurobiol. 2013 Aug;23(4):539-45
references.pmid: 23375167
references.citation: Annu Rev Public Health. 2013;34:253-70
references.pmid: 23297659
references.citation: Neurotox Res. 2008 Oct;14(2-3):169-83
references.pmid: 19073424
references.citation: Mol Psychiatry. 2013 Sep;18(9):1025-33
references.pmid: 23711983
references.citation: Expert Opin Pharmacother. 2014 Mar;15(4):471-81
references.pmid: 24456374
references.citation: Clin Pharmacol Ther. 2009 Apr;85(4):359-61
references.pmid: 19295534
references.citation: Behav Brain Res. 2002 Dec 2;137(1-2):75-114
references.pmid: 12445717
references.citation: J Neurosci. 2015 Jul 15;35(28):10290-303
references.pmid: 26180204